Barriers to antiretroviral initiation in HIV-1-discordant couples

Journal of Acquired Immune Deficiency Syndromes

Volumn 58, Issue 3, 2011, Pages

  Guthrie, Brandon L ^a   Choi, Robert Y ^a   Liu, Amy Y ^a   MacKelprang, Romel D ^a   Rositch, Anne F ^b   Bosire, Rose ^c   Manyara, Lucy ^d   Gatuguta, Ann ^e   Kiarie, James N ^f,g   Farquhar, Carey ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d Kenya Medical Training College Nairobi   (Kenya)

^e KENYATTA UNIVERSITY   (Kenya)

^f UNIVERSITY OF NAIROBI   (Kenya)

^g KENYATTA NATIONAL HOSPITAL   (Kenya)

Author keywords

antiretroviral; ART; discordant couples; HAART; HIV; serodiscordant

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; EARLY INTERVENTION; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; KENYA; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PREGNANCY RATE; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIAL STATUS; THERAPY DELAY; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FAMILY CHARACTERISTICS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; KENYA; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; TIME FACTORS; VIRAL LOAD;

EID: 80054892279     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31822f064e     Document Type: Article

References (22)

1. Palella FJ, Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338: 853-860. (Pubitemid 28135961)
2. Vittinghoff E, Scheer S, O'Malley P, et al. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. J Infect Dis. 1999;179:717-720. (Pubitemid 30016162)
3. Attia S, EggerM, Muller M, et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23:1397-1404.
4. UNAIDS. AIDS Epidemic Update: November 2009. Geneva, Switzerland: WHO; November 2009.
5. Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375:2092-2098.
6. Lingappa JR, Hughes JP, Wang RS, et al. Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS One. 2010;5:e12598.
7. Reynolds SJ, Makumbi F, Nakigozi G, et al. HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy. AIDS. 2011;25:473-477.
8. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342:921-929. (Pubitemid 30177052)
9. Bassett IV, Regan S, Chetty S, et al. Who starts antiretroviral therapy in Durban, South Africa? Not everyone who should. AIDS. 2010;24(suppl 1):S37-S44.
10. Bassett IV, Wang B, Chetty S, et al. Loss to care and death before antiretroviral therapy in Durban, South Africa. J Acquir Immune Defic Syndr. 2009;51:135-139.
11. Larson BA, Brennan A, McNamara L, et al. Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Trop Med Int Health. 2010;15(suppl 1):43-47.
12. Dahab M, Charalambous S, Karstaedt AS, et al. Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort study. BMC Public Health. 2010;10:430.
13. Emery S, Bodrug S, Richardson BA, et al. Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol. 2000;38:2688-2695. (Pubitemid 30485151)
14. Guthrie BL, Choi RY, Bosire R, et al. Predicting pregnancy in HIV-1-discordant couples. AIDS Behav. 2010;14:1066-1071.
15. Keiser O, Anastos K, Schechter M, et al. Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health. 2008;13:870-879. (Pubitemid 351813514)
16. Laher F, Todd CS, Stibich MA, et al. A qualitative assessment of decisions affecting contraceptive utilization and fertility intentions among HIV-positive women in Soweto, South Africa. AIDS Behav. 2009;13 (suppl 1):47-54.
17. Sturt AS, Dokubo EK, Sint TT. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Cochrane Database Syst Rev. 2010;3: CD008440.
18. Taulo F, Berry M, Tsui A, et al. Fertility intentions of HIV-1 infected and uninfected women in Malawi: a longitudinal study. AIDS Behav. 2009;13 (suppl 1):20-27.
19. Homsy J, Bunnell R, Moore D, et al. Reproductive intentions and outcomes among women on antiretroviral therapy in rural Uganda: a prospective cohort study. PLoS ONE. 2009;4:e4149.
20. Myer L, Morroni C, Rebe K. Prevalence and determinants of fertility intentions of HIV-infected women and men receiving antiretroviral therapy in South Africa. AIDS Patient Care STDS. 2007;21:278-285. (Pubitemid 46676683)
21. Myer L, Carter RJ, Katyal M, et al. Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study. PLoS Med. 2010;7:e1000229.
22. Duff P, Kipp W, Wild TC, et al. Barriers to accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a regional hospital in western Uganda. J Int AIDS Soc. 2010;13:37.